DK136976C - - Google Patents

Info

Publication number
DK136976C
DK136976C DK169573A DK169573A DK136976C DK 136976 C DK136976 C DK 136976C DK 169573 A DK169573 A DK 169573A DK 169573 A DK169573 A DK 169573A DK 136976 C DK136976 C DK 136976C
Authority
DK
Denmark
Application number
DK169573A
Other languages
Danish (da)
Other versions
DK136976B (da
Inventor
W A Bolhofer
Original Assignee
Merck & Co Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc. filed Critical Merck & Co Inc.
Publication of DK136976B publication Critical patent/DK136976B/da
Application granted granted Critical
Publication of DK136976C publication Critical patent/DK136976C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK169573AA 1972-04-11 1973-03-28 Analogifremgangsmåde til fremstilling af 2-(alfa-(3-trifluormethylphenoxy)-4-chlorbenzyl)-2-oxazolin eller syreadditionssalte deraf. DK136976B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00243480A US3816446A (en) 1972-04-11 1972-04-11 (alpha-(3-trifluoromethylphenoxy)-4-chlorobenzyl)heterocycles

Publications (2)

Publication Number Publication Date
DK136976B DK136976B (da) 1977-12-27
DK136976C true DK136976C (https=) 1978-06-05

Family

ID=22918919

Family Applications (1)

Application Number Title Priority Date Filing Date
DK169573AA DK136976B (da) 1972-04-11 1973-03-28 Analogifremgangsmåde til fremstilling af 2-(alfa-(3-trifluormethylphenoxy)-4-chlorbenzyl)-2-oxazolin eller syreadditionssalte deraf.

Country Status (9)

Country Link
US (1) US3816446A (https=)
JP (1) JPS5030620B2 (https=)
CH (1) CH589636A5 (https=)
DE (1) DE2318002A1 (https=)
DK (1) DK136976B (https=)
FR (1) FR2182952B1 (https=)
GB (1) GB1388790A (https=)
NL (1) NL7304333A (https=)
SE (1) SE380524B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953465A (en) * 1972-04-11 1976-04-27 Merck & Co., Inc. 2-[α-(3-Trifluoromethylphenoxyl)-4-chlorobenzyl]oxazole and methods for preparing the same
US3953490A (en) * 1972-07-13 1976-04-27 Merck & Co., Inc. Preparation of (3-trifluoromethylphenoxy)(4-chlorophenyl)acetonitrile
JPS50116306U (https=) * 1974-03-05 1975-09-22
JPS50137193U (https=) * 1974-04-25 1975-11-12
JPS5111502A (en) * 1974-07-19 1976-01-29 Matsushita Electric Industrial Co Ltd Senkyokusochi
JPS544877Y2 (https=) * 1976-12-03 1979-03-01
EP0035475B1 (de) * 1980-03-05 1983-11-30 Ciba-Geigy Ag Herbizid wirkende 2-Nitro-5-phenoxyphenyl-oxazole, -oxazine, -imidazole, -pyrimidine und -thiazole, ihre Herstellung und Verwendung
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
FR2766821A1 (fr) * 1997-07-29 1999-02-05 Sanofi Sa Derives de 1,3-oxazolinyl-biphenyle, leur procede de preparation et leur utilisation comme intermediaires de synthese
AU2002251978B2 (en) * 2001-02-09 2007-07-19 Merck & Co., Inc. 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
US7371888B2 (en) * 2004-02-18 2008-05-13 Metabolex, Inc. α-(Trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
AU2005247473A1 (en) 2004-05-25 2005-12-08 Metabolex, Inc. Substituted triazoles as modulators of PPAR and methods of their preparation

Also Published As

Publication number Publication date
FR2182952A1 (https=) 1973-12-14
NL7304333A (https=) 1973-10-15
FR2182952B1 (https=) 1975-10-31
US3816446A (en) 1974-06-11
DE2318002A1 (de) 1973-10-31
GB1388790A (en) 1975-03-26
JPS5030620B2 (https=) 1975-10-02
DK136976B (da) 1977-12-27
CH589636A5 (https=) 1977-07-15
JPS497275A (https=) 1974-01-22
SE380524B (sv) 1975-11-10

Similar Documents

Publication Publication Date Title
FR2195255A5 (https=)
FR2182952B1 (https=)
JPS4934056U (https=)
JPS55960B2 (https=)
JPS4983363A (https=)
JPS48100984U (https=)
JPS4917995A (https=)
JPS5318747Y2 (https=)
CS152731B1 (https=)
JPS505065A (https=)
CS152699B1 (https=)
JPS4978403U (https=)
CS152691B1 (https=)
CS152525B1 (https=)
CS150857B1 (https=)
JPS476138U (https=)
CS151397B1 (https=)
CS152931B1 (https=)
CS153297B1 (https=)
CS153933B1 (https=)
CH562033A5 (https=)
CH603715A5 (https=)
BG25975A1 (https=)
CH562080A5 (https=)
CH562183A5 (https=)